XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATIO (Tables)
6 Months Ended
Jun. 26, 2021
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity was as follows:

 

       Weighted Average 
   Shares   Grant Fair Value 
Balance, December 26, 2020   3,051,874   $1.67 
Granted   1,486,843    3.03 
Forfeited   (985,000)   1.81 
Vested   (1,010,000)   2.44 
Balance, June 26, 2021   2,543,717   $2.11 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and six months ended June 26, 2021 and June 27, 2020 (no tax benefits were recognized):

 

   Three Months Ended   Three Months Ended  

Six Months

Ended

  

Six Months

Ended

 
   June 26, 2021   June 27, 2020   June 26, 2021   June 27, 2020 
Cost of product revenues  $34,789   $16,226   $168,573   $30,246 
Research and development   121,012    57,523    215,065    112,655 
Selling, general and administrative   358,708    87,885    2,741,037    177,241 
Total  $514,509   $161,677   $3,124,675   $320,142